Neoplasia/BPH

	Bladder-sparing chemoradiotherapy following neoadjuvant chemotherapy for muscle-invasive bladder cancer: a retrospective cohort study. BMC Urol Mofid B, Jafari A, Simforoosh N, Basiri A, Siavashpour M, Siavashpour Z, Zabihi MS, Ghajari M, Razzaghdoust A. PMID: 42185887 [PubMed - as supplied by publisher]
	Overdiagnosis in renal cancer: the hidden consequence of modern imaging. Int Urol Nephrol Vallecilla Valencia K, Garcia-Perdomo HA. PMID: 42185723 [PubMed - as supplied by publisher]
	ASO Author Reflections: Refining CT Heterogeneity Scoring to Improve Clear Cell Renal Cell Carcinoma Diagnosis in Small Renal Masses. Ann Surg Oncol Zhang W, Li X, Zhu X, Song X, Qu J. PMID: 42185708 [PubMed - as supplied by publisher]
	Impact of frailty on perioperative and oncologic outcomes after robotic radical prostatectomy: a multicenter study with competing risk analysis. J Robot Surg Rabie A, Dovey Z, Falavolti C, Papalia R, Signore S, Martini A, Marco MD, Balah A, Petitti T, Buscarini M, Zaytoun O. PMID: 42185689 [PubMed - indexed for MEDLINE]
	Multi-omics analysis reveals TM4SF19 as a diagnostic and prognostic biomarker in bladder cancer. Discov Oncol Aizezi X, Silafu B, Shi H, Huang J. PMID: 42185687 [PubMed - as supplied by publisher]
	Preoperative lung immune prognostic index (LIPI) predicts postoperative outcomes in clear cell renal cell carcinoma: a multicenter study. Sci Rep Pan Z, Li Y, Lou J, Shan S, Guo Y, Jiang S, He Q, Zhou G, Yang L. PMID: 42185427 [PubMed - as supplied by publisher]
	Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial. Nat Commun Johnson JS, Miller JW, Hatoum F, Schell MJ, Yu X, Roman Souza G, Mizelle S, Gullapalli K, Fazili A, Jain R, Chatzkel J, Cen L, Dhillon J, Cubitt C, Yao J, Whiting J, Li J, Swank J, Jameel G, Zhang J, Wang X, Spiess PE, Fishman M, Chahoud J. PMID: 42185255 [PubMed - as supplied by publisher]
	NCCN Guideline Updates on Radiopharmaceutical Therapy for Prostate Cancer. Eur Urol Focus Ravi P, Dorff TB, Morgans AK. PMID: 42185202 [PubMed - as supplied by publisher]
	Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification. Semin Diagn Pathol Nguyen JK. PMID: 42185133 [PubMed - as supplied by publisher]
	Laparoscopic retroperitoneal lymph node dissection in testicular cancer: feasibility and safety at a tertiary center. Cir Cir Scavuzzo A, Calvo-Vázquez I, Reynoso-Noveron N, Pierzo-Lugo C, Barajas-Narvaez E, Jiménez-Ríos MA. PMID: 42184400 [PubMed - indexed for MEDLINE]
	Beyond the stone: nephrolithiasis as a metabolic sentinel in upper tract urothelial carcinoma and papillary renal cell carcinoma: toward a risk-stratified management framework. Int Urol Nephrol Wan S, Gao S, Huang K, Bai Y. PMID: 42184081 [PubMed - as supplied by publisher]
	A nomogram predicting the OS and CSS ofâ€‰â‰¥â€‰T1b renal cell carcinoma patients after surgery. Clin Transl Oncol Zheng J, Wang H, Lv J, Liu C, Lan X, Xu T, Feng M. PMID: 42184075 [PubMed - as supplied by publisher]
	Improving Clear Cell Renal Cell Carcinoma Diagnosis: Modified CT Algorithms with Simplified Heterogeneity Scoring. Ann Surg Oncol Zhang W, Chen Q, Zhu X, Li X, Wang X, Ma H, Song X, Zheng Z, Qu J. PMID: 42183967 [PubMed - as supplied by publisher]
	Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancer. Ther Adv Med Oncol Bilen MA, Lowentritt BH, Burbage S, Patel C, Rossi C, Kinkead F, Wong G, Pilon D, Shore ND. PMID: 42182602 [PubMed]
	Identification of shared diagnostic biomarkers and molecular pathways between chronic kidney disease and renal cell carcinoma using transcriptomics and machine learning. Transl Cancer Res Peng X, Wang Z, Si J, Ji H, Xu G, Chen Y, Du M, Xu M. PMID: 42180890 [PubMed]
	Low follow-up rate after positive prostate cancer screening in southern China: a community-based cross-sectional survey with a prospective component. Front Public Health Li ZQ, Li JR, Li Y, Liang YF, Bi JW, Li W. PMID: 42180501 [PubMed - indexed for MEDLINE]
	Application and challenges of smart responsive multifunctional nanoplatforms in integrated diagnosis and treatment of bladder cancer and overcoming therapeutic resistance. Front Oncol Chen L, Hang G, Wen Q, Ren L, Chen B. PMID: 42180091 [PubMed]
	Association between BK polyomavirus and prostate cancer: a systematic review and meta-analysis. Front Oncol Xiang B, Wang S, Zhang X, Zhao J, Zhang M, He J. PMID: 42180090 [PubMed]
	Liquid biopsy-based epigenetic signatures for early detection of prostate cancer: a systematic review. Front Oncol Cleanclay WD, Kintung IF, Kernyuy FB, Yensii NG, Fagbohun BO, Amadi EC, Kaze NN. PMID: 42180075 [PubMed]
	A prospective comparison of the diagnostic performance of a high b-value diffusion-weighted image-guided score versus PI-RADS v2.1 for transition zone prostate cancer. Front Oncol Li K, Xu T, Yan X, Mi S, Jiang M, Chen L, Kuang F. PMID: 42180067 [PubMed]

Articles 1 - 20 / 188100

Page 1 of 9405



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy